Clinical trials: Lower Cross Syndrome
Lower Limb Apophysitis (Severs, Osgood Schlatter, Sinding-Larsen Johansson)
Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status
Lower limb apophysitis cause long-term pain, decrease in function, and can reduce or completely hinder participation in sports and physical activity, yet there is little knowledge on the long-term consequences for health.
- Trial name
- NCT04313621
- Where
- Denmark
- Volunteers
- 1,218 people, healthy volunteers welcome
- Sponsor
- Hvidovre University Hospital
Gastro Esophageal Reflux
Effect of Citalopram on Reflux Episodes in Healthy Volunteers
Citalopram is sometimes used in the treatment for gastro-esophageal reflux disease, however, there are no empirical data to support this.
- Trial name
- NCT03746691
- Testing
- Citalopram HCl
- Where
- Belgium
- Volunteers
- 19 people, healthy volunteers welcome
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Lower Cross Syndrome
Effects of Bruegger's Exercises Versus Egoscue Exercise on Lower Cross Syndrome
This study aims to find effects of Bruegger's Exercise versus Egoscue exercise on pain and hyperlordosis on patient with lower cross syndrome. This is interventional study which recruits 34 participants ,14 in each group.
- Trial name
- NCT06303388
- Testing
- Bruegger,s Exercise, Egoscue Exercise
- Where
- Pakistan
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Riphah International University
Lower Respiratory Tract Disease, Healthy Participants
Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults
This study is being done to find out how safe and effective a new combined vaccine candidate, called VXB-251, is for older adults.
- Trial name
- VXB251-001 (NCT07295028)
- Testing
- trivalent (RSV/hMPV/PIV3) vaccine candidate, bivalent (RSV/hMPV) unlicensed comparator, monovalent (RSV) unlicensed comparator
- Where
- 6 sites in Australia
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Sanofi
Cholesterol Absorption
GPur- Luminating Oral Cholesterol Kinetics Pilot Study
In healthy subjects not receiving or requiring lipid lowering therapy and who do not have diabetes, the use of clinoptilolite (GPUR) will result in a reduction of absorbed dietary cholesterol observed over 6 days of therapy.
- Trial name
- GLOCK-pilot (NCT03090542)
- Testing
- clinoptilolite
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Canadian Collaborative Research Network
Edentulous Mouth, Quality of Life
Impact of Retro-molar Pad Demarcation on Complete Denture Wearers' Satisfaction
the retromolar pad is a critical anatomical landmark in the lower edentulous arch marking the posterior end of any removable prosthesis.
- Conditions
- Edentulous Mouth, Quality of Life, Patient Satisfaction, Complete Edentulism
- Trial name
- RMP (NCT07246343)
- Testing
- carving of retromolar pad area (RMP), no carving of the retromolar pad area (RMP)
- Where
- Jordan
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Samiha Sartawi